Assessment of the Association of HIV Infection with Hepatic Steatosis or Fibrosis: a Cross-sectional Case–Control Study

Human immunodeficiency virus (HIV) infection and antiretroviral therapy have been associated with non-alcoholic fatty liver disease (NAFLD), but few studies evaluated whether HIV is an independent risk factor for the development of hepatic steatosis advanced fibrosis. To study prevalence severity fibrosis in people living control outpatients. We conducted a cross-sectional analysis relevant data from 875 pairs individuals belonging to HIV-dedicated outpatient clinic adult primary care inner-city hospital. Hepatic Steatosis Index (HSI) FIB-4 index were calculated as non-invasive measures fibrosis, respectively. A multivariate logistic regression was performed assess predictors The steatosis, determined by HSI ≥ 36, higher HIV-negative subjects (71.5% vs. 65.4%, p = 0.006). 3.25, HIV-positive group (7% 1.7%, < 0.001). Multivariable did not identify be (p 0.068) In this cohort, more prevalent non-HIV infected patients, while had HIV. found either or